World's Largest Resource for Cardiovascular Perfusion

Perfusion StaffingPerfusion Staffing
   +1 888-499-5672Login
Perfusion NewswireMain ZoneDisseminated Malignancy after Extracorporeal Life Support and Left Ventricular Assist Device, Diagnosed by Left Ventricular Apical Core Biopsy

Disseminated Malignancy after Extracorporeal Life Support and Left Ventricular Assist Device, Diagnosed by Left Ventricular Apical Core Biopsy

Main Zone, Mobile Zone, Perfusion Devices, Perfusion Zone


The left ventricular apical core biopsy performed during implantation of a left ventricular assist device (VAD) is a well-known diagnostic procedure in confirming cardiomyopathies leading to end-stage heart failure. We describe a patient in whom disseminated malignancy was revealed by means of the apical core biopsy after extracorporeal life support and left ventricular assist device implantation as a bridge to transplantation. This case emphasizes the importance of thorough oncological screening before VAD implantation and the possible consequences of circulating tumour cells in this device-assisted circulation.


Leave a Reply

You may also like
Pediatric Zone, Perfusion Devices, Perfusion Zone, Tiny Perfusion Letter

The Effect of Selective Cerebral Perfusion on Cerebral versus Somatic Tissue Oxygenation During Aortic Coarctation Repair in Neonates and Infants

SctO2 and SstO2 have distinct patterns of changes before and after aortic opening during neonate/infant aortic coarctation repair. SctO2/SstO2’s correlations with MAP and PaCO2 are confounded by SCP. The outcome impact of combined SctO2/SstO2 monitoring remains to be studied.

Join TodayJoin Today